Clinical trial
The Impact of CPAP on Glucose Metabolism in Moderate-Severe Obstructive Sleep Apnoea Patients Without Diabetes - An Observational Study
NCT05335083 is registered in ClinicalTrials.gov with Woolcock Institute of Medical Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of CPAP on Glucose Metabolism in Moderate-Severe Obstructive Sleep Apnoea Patients Without Diabetes - An Observational Study
- Lead sponsor
- Woolcock Institute of Medical Research
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- July 1, 2025
- Completion date
- February 28, 2027
- Enrollment
- 100 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
obstructive sleep apnea, pre-diabetes